Pharmacy amalgamation & consolidation applications

Consolidation — sometimes called amalgamation — is the process of combining two or more NHS pharmacy contracts so that one pharmacy ceases to operate and its contract is transferred to, or absorbed by, another existing pharmacy. The process is regulated under Regulation 26A of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 and requires ICB approval. The ICB must be satisfied that consolidation would not create an unacceptable gap in pharmaceutical service provision for the local population.

The ICB will assess whether granting consolidation would leave a gap in essential pharmaceutical services for patients who currently rely on the pharmacy that would close. If the ICB concludes that patients' needs can be met by other pharmacies in the area, consolidation is more likely to be approved. TI Pharmacy Consultancy assesses the viability of consolidation at the outset before any application is submitted.

Yes — consolidation typically involves transferring the contract of one pharmacy onto the premises of another pharmacy already operated by the same contractor. This is a common route for pharmacy owners looking to rationalise their portfolio. TI Pharmacy Consultancy advises on the regulatory requirements and manages the application.

The timeline depends on the complexity of the application and whether the ICB requires additional information or convenes a hearing. TI Pharmacy Consultancy advises on realistic timelines based on the specific circumstances and manages the process throughout.

Market exit refers to a pharmacy voluntarily giving up its NHS contract without transferring it elsewhere — effectively closing. Consolidation involves the contract continuing in a different form at a different location. Market exit has different regulatory implications and may affect the pharmaceutical list for the area. TI Pharmacy Consultancy advises on both routes and the implications of each.